FDA.reportPublic FDA data

Evrysdi 0.75 MG/mL Oral Solution

RxCUI
2390946
RxNorm name
Evrysdi 0.75 MG/mL Oral Solution
Display name
Evrysdi 0.75 MG/mL Oral Solution
Full name
Evrysdi 0.75 MG/mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eceb9a99-7191-4be5-87c3-0102707cf98eEvrysdi 0.75 MG/mL Oral Solution [PSN] · risdiplam 0.75 MG/ML Oral Solution [Evrysdi] [SBD] · Evrysdi 0.75 MG/ML Oral Solution [SY] · Evrysdi 60 MG per 80 ML Oral Solution [SY]426These highlights do not include all the information needed to use EVRYSDI safely and effectively. See full prescribing information for EVRYSDI. EVRYSDI ® (risdiplam) for oral solution EVRYSDI ® (risdiplam) tablets, for oral use Initial U.S. Approval: 202020260219